Expertise in
12
conditions

Dr. Taher B. Abu Hejleh

Oncology
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City, IA 
Accepting New Patients
Expertise in
12
conditions
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City, IA 

Overview

Taher Abu Hejleh is an Oncologist practicing medicine in Iowa City, Iowa.

Dr. Abu Hejleh is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 2 clinical trials. Dr. Abu Hejleh is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in IA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medica
  • EPO
  • HMO
  • PPO
Sanford Health
  • HMO
  • PPO

Locations

University of Iowa Stead Family Children's Hospital
200 Hawkins Dr, Iowa City, IA 52242

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Trial of High-Dose Ascorbate in Stage IV Non-Small Cell Lung Cancer
A Phase II Trial of High-Dose Ascorbate in Stage IV Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: August 20, 2024
Intervention Type: Drug
Study Drugs: Paclitaxel, Carboplatin, Ascorbic Acid
Study Phase: Phase 2
A Phase I Trial of a Ketogenic Diet With Concurrent Chemoradiation for Head and Neck Cancer
A Phase I Trial of a Ketogenic Diet With Concurrent Chemoradiation for Head and Neck Cancer
Enrollment Status: Terminated
Publish Date: June 26, 2018
Intervention Type: Dietary supplement, Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

24 Total Publications

Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity.
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 17, 2025
Similar Doctors
Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (0.1 miles away)
319-356-2015
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Bender is an Oncologist practicing medicine in Iowa City, Iowa. Dr. Bender is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Bladder Reconstruction, and Hernia Surgery. Dr. Bender is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (0.1 miles away)
319-356-2015
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Michael Goodheart is an Oncologist practicing medicine in Iowa City, Iowa. Dr. Goodheart is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Vulvar Cancer, Hernia Surgery, and Salpingo-Oophorectomy. Dr. Goodheart is currently accepting new patients.

Expertise in
35
conditions
Expertise in
35
conditions
Referral may be required

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (0.1 miles away)
319-356-4019
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Varun Monga is an Oncologist practicing medicine in Iowa City, Iowa. Dr. Monga is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Oligodendroglioma, Astrocytoma, Glioblastoma, and Embryonal Tumor with Multilayered Rosettes.

Frequently Asked Questions about Dr. Taher B. Abu Hejleh

How do I make an appointment with Dr. Taher B. Abu Hejleh?

You can book an appointment with Dr. Taher B. Abu Hejleh by calling their office at 319-356-2075. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Taher B. Abu Hejleh a top-rated expert for Pleuropulmonary Blastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Taher B. Abu Hejleh is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Taher B. Abu Hejleh specialize in?

While Dr. Taher B. Abu Hejleh is a Oncology, they have specific expertise in Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Taher B. Abu Hejleh participate in research or clinical trials?

Yes. Dr. Taher B. Abu Hejleh has published 24 articles and abstracts on conditions like Pleuropulmonary Blastoma. You can view a list of Dr. Taher B. Abu Hejleh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Taher B. Abu Hejleh accept my insurance?

Dr. Taher B. Abu Hejleh accepts most major insurance plans, including Medica and Sanford Health. We recommend calling the office directly at 319-356-2075 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Abu Hejleh's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 16 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile